Synthetic Cannabinoid-Induced Psychosis: Two Adolescent Cases

Benford DM , Caplan JP . Psychiatric sequelae of Spice, K2, synthetic cannabinoid receptor agonists. Psychosomatics, 52:295. 2011.

Cary P . Emerging issue: Spice, K2, the problem of synthetic cannabinoids. National Drug Court Institute, 2010a. Alexandria, VA.

Cary P . Questions, answers: Synthetic cannabinoids (Spice, K2, etc.) National Drug Court Institute, 2010b. Alexandria, VA.

Castellanos D , Singh S , Thornton G , Avila M , Moreno A . Synthetic cannabinoid use: A case series of adolescents. J Adolesc Health, 49:347–349. 2011.

Coulter C , Garnier M , Moore C . Synthetic cannabinoids in oral fluid. J Anal Toxicol, 35:424–430. 2011.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Understanding the Spice phenomenon, EMCDDA thematic paper. European Monitoring Centre for Drugs and Drug Addiction, 2009 Lisbon, Portugual.

Every–Palmer S . Synthetic cannabinoid JWH-018 and psychosis: An explorative study. Drug Alcohol Depend, 117:152–157. 2011.

Huffman JW , Duncan SG . Synthesis and pharmacology of the 1’, 2’-dimethylheptyl-Δ8-THC isomers: Exceptionally potent cannabinoids. Bioorgan Med Chem Lett, 7:2799–2804. 1997.

Huffman JW , Mabon R , Wu MJ , Lu J , Hart R , Hurst DP , Reggio PH , Wiley JL , Martin BR . 3-Indolyl-1-naphthylmethanes: New cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB1 cannabinoid receptor. Bioorgan Med Chem, 11:539–549. 2003.

Huffman JW , Zengin G , Wu MJ , Lu J , Hynd G , Bushell K , Thompson AL , Bushell S , Tartal C , Hurst DP , Reggio PH , Selley DE , Cassidy MP , Wiley JL , Martin BR . Structure–activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: Steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonists. Bioorgan Med Chem, 13:89–112. 2005.

Hurst D , Loeffler G , McLay R . Psychosis associated with synthetic cannabinoid agonists: A case series. Am J Psychiatry, 168:1119. 2011.

Moore C , Coulter C , Uges D , Tuyay J , Van der Linde S , Leeuwen A , Garnier M , Orbita J . Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Sci Int, 212:227–230. 2011.

National Forensic Laboratory Information System (NFLIS): Special report. Synthetic cannabinoids and synthetic cathinones reported in the National Forensic Laboratory Information System (NFLIS), 2009–2010 Springfield, VA.

Nutt D . Advisory Council on the Misuse of Drugs (ACMD): Consideration of the major cannabinoid agonists. London: Advisory Council on the Misuse of Drugs, 2009.

Pierre MJ . Cannabis, synthetic cannabinoids, psychosis risk: What the evidence says. Curr Psychiatr, 10:49. 2011.

Seely KA , Prather PL , James LP , Moran JH . Marijuana-based drugs: Innovative therapeutics or designer drugs of abuse? Mol Interv, 11:36–51. 2011.

United States Drugs Enforcement Administration: U.S. Department of Justice. Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids Into Schedule I21 CFR Part 1308Springfield, VA.